BDNF and postpartum depression: The results we found in the literature regarding BDNF changes in humans treated with esketamine are mostly from studies of specific populations (Table 2): one study reported that intravenous esketamine at a dose of 0.25 mg/kg significantly increased plasma BDNF levels in patients with postpartum depression, with this increase measured three days after infusion [104].